Paradigm shift in determining Neoproterozoic atmospheric oxygen
نویسندگان
چکیده
منابع مشابه
Paradigm shift in determining Neoproterozoic atmospheric oxygen
We present a new and innovative way of determining the oxygen level of Earth’s past atmosphere by directly measuring inclusion gases trapped in halite. After intensive screening using multiple depositional, textural/fabric, and geochemical parameters, we determined that tectonically undisturbed cumulate, chevron, and cornet halite inclusions may retain atmospheric gas during crystallization fro...
متن کاملParadigm Shift
A paradigm shift, suggested by Thomas Kuhn [1], is not just a small change in science, or the modification of a theory. It is a scientific revolution and completely changes the way in which science looks at the world. It often dictates how the public looks at the world. For example, Darwin's theories [2] were intensely debated by scientists and theologians. This debate spilled over into the pub...
متن کاملA Methodology for Paradigm Shift to Explain Sustainable University
The sustainable university concept is rooted in prevalent paradigms pertained to economic, social and environmental development, which all focus on systemic thought and rationality; besides, they tend to discover and solve problems by applying an interdisciplinary approach. However, the epistemic component is what these paradigms have ignored. The purpose of this study is to explain a methodo...
متن کاملParadigm Shift in Reconfigurable Computing
As per the Moore's law, the number of transistors that could be placed on a single integrated circuit has been increasing exponentially, and today has reached the stage where the implementation of multiple processor cores on a single chip has become a reality. As a result, the capacity of modern FPGA devices will soon support the implementation of hundreds to thousands of soft microprocessor co...
متن کاملBortezomib paradigm shift in myeloma.
Bortezomib (Velcade, formerly PS-341) is a peptide boronate inhibitor of the proteasome that was developed for cancer therapy by Julian Adams, Peter Elliott, and their colleagues.1 At the time, this was considered a very bold move, since loss of proteasome function was thought to be incompatible with viability in normal cells. However, using a novel assay that directly measures 20S proteasome a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Geology
سال: 2016
ISSN: 0091-7613,1943-2682
DOI: 10.1130/g37937.1